# Bruton's tyrosine kinase inhibition—An emerging therapeutic strategy in immune‐mediated dermatological conditions

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bruton-s-tyrosine-kinase-inhibition-an-emerging-therapeutic-strategy-in-immune/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Pedro Mendes‐Bastos,Ana Brasileiro,Pavel Kolkhir,Stefan Frischbutter,Jörg Scheffel,Sherezade Moñino‐Romero,Marcus Maurer |
| Citations | 96 |
| DOI | 10.1111/all.15261 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.15261 |
| OpenAlex ID | https://openalex.org/W4213337080 |
| PMID | 35175630 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Pedro Mendes‐Bastos](https://scholariq.org/researchers/pedro-mendes-bastos/)

## Paper journal

- [Allergy](https://scholariq.org/journals/allergy/)

## Paper primary topic

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Paper topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.